doi: 10.1001/jama.2024.2252.
GLP-1 Agonists for Obesity-A New Recipe for Success?
Affiliations
- PMID: 38421659
- DOI: 10.1001/jama.2024.2252
Item in Clipboard
GLP-1 Agonists for Obesity-A New Recipe for Success?
JAMA.
.
No abstract available
Plain language summary
This Viewpoint discusses the drawbacks of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity and presents an alternative approach of initial, staged GLP-1 agonist treatment supported by long-term lifestyle programming, including medically appropriate groceries or meals (“Food Is Medicine”), to address the cost, health, and equity burdens of obesity.
Comment in
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):673-674. doi: 10.1001/jama.2024.12068. JAMA. 2024. PMID: 39083262 No abstract available.
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):674-675. doi: 10.1001/jama.2024.12065. JAMA. 2024. PMID: 39083266 No abstract available.
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):672-673. doi: 10.1001/jama.2024.12071. JAMA. 2024. PMID: 39083283 No abstract available.
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):673. doi: 10.1001/jama.2024.12074. JAMA. 2024. PMID: 39083284 No abstract available.
Similar articles
-
Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists.N Engl J Med. 2024 May 30;390(20):1839-1842. doi: 10.1056/NEJMp2400978. Epub 2024 Apr 17. N Engl J Med. 2024. PMID: 38630999 No abstract available.
-
DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.J Endocrinol Invest. 2020 May;43(5):653-662. doi: 10.1007/s40618-019-01153-z. Epub 2019 Nov 30. J Endocrinol Invest. 2020. PMID: 31786794
-
Role of glucagon-like peptide 1 receptor agonists in management of obesity.Am J Health Syst Pharm. 2016 Oct 1;73(19):1493-507. doi: 10.2146/ajhp150990. Epub 2016 Aug 12. Am J Health Syst Pharm. 2016. PMID: 27521241 Review.
-
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26. Expert Opin Pharmacother. 2014. PMID: 25260877 Review.
-
New Injectable Agents for the Treatment of Type 2 Diabetes Part 2-Glucagon-Like Peptide-1 (GLP-1) Agonists.Am J Med. 2018 Nov;131(11):1304-1306. doi: 10.1016/j.amjmed.2018.05.043. Epub 2018 Jul 2. Am J Med. 2018. PMID: 29969616 Review.
Cited by
-
Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.Int J Obes (Lond). 2025 Aug 13. doi: 10.1038/s41366-025-01859-6. Online ahead of print. Int J Obes (Lond). 2025. PMID: 40804463
-
Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians.Obes Pillars. 2024 Oct 13;12:100143. doi: 10.1016/j.obpill.2024.100143. eCollection 2024 Dec. Obes Pillars. 2024. PMID: 39498283 Free PMC article.
-
Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy.Amino Acids. 2025 May 8;57(1):25. doi: 10.1007/s00726-025-03454-5. Amino Acids. 2025. PMID: 40338379 Free PMC article. Review.
-
Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.Obesity (Silver Spring). 2025 Aug;33(8):1475-1503. doi: 10.1002/oby.24336. Epub 2025 May 30. Obesity (Silver Spring). 2025. PMID: 40445127 Free PMC article.
-
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.Obes Pillars. 2025 Jun 3;15:100181. doi: 10.1016/j.obpill.2025.100181. eCollection 2025 Sep. Obes Pillars. 2025. PMID: 40673264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
